INITIAL PUBLIC OFFERING	3 Months Ended
Mar. 31, 2022
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering on March 28, 2022, and the underwriters’ exercise of the over-allotment option on March 30, 2022, the Company sold 11,500,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock, one right to receive one-tenth (1/10) of one share of Class A common stock, and one redeemable warrant (each, a “Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 7). As of March 28, 2022, the Company accounted for the underwriter’s over-allotment option as a liability in accordance with ASC 480, with a value of $65,260. The option was measured at fair value utilizing a Black Scholes Model, which includes the following assumptions of stock price, exercise price, volatility, term, and the risk-free rate. The liability was extinguished upon the exercise of the over-allotment option on March 30, 2022. The change in fair value between March 28, 2022 and March 30, 2022 was de minimis and therefore had no impact on the Company’s statement of operations for the three months ended March 31, 2022.

INITIAL PUBLIC OFFERING

3 Months Ended

Mar. 31, 2022

NOTE 3. INITIAL PUBLIC OFFERING

Pursuant to the Initial Public Offering on March 28, 2022, and the underwriters’ exercise of the over-allotment option on March 30, 2022, the Company sold 11,500,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of Class A common stock, one right to receive one-tenth (1/10) of one share of Class A common stock, and one redeemable warrant (each, a “Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 7).

As of March 28, 2022, the Company accounted for the underwriter’s over-allotment option as a liability in accordance with ASC 480, with a value of $65,260. The option was measured at fair value utilizing a Black Scholes Model, which includes the following assumptions of stock price, exercise price, volatility, term, and the risk-free rate. The liability was extinguished upon the exercise of the over-allotment option on March 30, 2022. The change in fair value between March 28, 2022 and March 30, 2022 was de minimis and therefore had no impact on the Company’s statement of operations for the three months ended March 31, 2022.